OxySure Systems (OXYS) To Host Investor Webcast at 11:30 am ET on May 16 , 2013

FRISCO, Texas, May 8, 2013 (GLOBE NEWSWIRE) -- OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it will hold a webcast at 11:30 am ET on Thursday, May 16, 2013 to discuss its growth strategy. The Company plans to file its 10Q for the first quarter ending March 31, 2013 by May 14, 2013.

Mr. Julian Ross, CEO of OxySure, will host the webcast. To attend, please use the dial in information below.

Date:                                     Thursday, May 16, 2013

Time:                                     11:30 am ET

US Dial-In:                           1-888-417-8533

International Dial-In:      1-719-325-2308                

Conference ID:                 9623052

Webcast:                             http://public.viavid.com/index.php?id=104735

Please register prior to the call using the instructions above. A copy of the presentation accompanying the webcast will be available on the Company’s website at www.oxysure.com prior to the call. Please contact Ted Haberfield at MZ Group if you are unable to access the presentation slides.

A playback of the call will be available until 11:59 pm ET on May 30, 2013. To listen, call +1-877-870-5176 within the United States or +1-858-384-5517 when calling internationally. Please use the replay PIN number 9623052. The playback of the call will also be made available on the investor relations section of the Company’s website.

About OxySure Systems, Inc.

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.

Contacts:

Investor Relations, US West:                                                      Investor Relations, US East:

MZ North America                                                                           Barwicki Investor Relations

Ted Haberfield, President                                                            Andrew Barwicki, President

Tel:         +1-760-755-2716                                                               Tel:         +1-516-662-9461

Email:    thaberfield@mzgroup.us                                             Email:    andrew@barwicki.com

Web:     www.mzgroup.us           

Media Relations:

Chris Castaldo

Tel:         +1-516-656-0217

Email:    chriscastaldo@aol.com